Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Semaphorin 3A Expression on Donor and Recipient Regulatory Cells: A Novel Pre-Transplant Biomarker Predicting the Development of Acute Graft-Versus-Host Disease

Zahava Vadas, MD PhD, Eti Ganon-Elazar, PhD, Yuval Nov, PhD, Israel Henig, MD, Dina Attias, MD, Nuhad Haddad, MD, Riva Fineman, MD, Jacob M. Rowe, MD, Tsila Zuckerman, MD

Blood (2014) 124 (21): 3935.

https://doi.org/10.1182/blood.V124.21.3935.3935

Published: 2014

Journal Articles

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Eldad J Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Elinor Sabbag, BSc., Marina Izak, MD, Abraham Korenberg, MD, Luiza Akria, MD, Dina Attias, MD, Kalman Filanovsky, MD, Uri Abadi, MD, Rosa Ruchlemer, MD, Roxolyana Abdah-Bortnyak, MD, Neta Goldschmidt, MD, Ron Epelbaum, MD, Netanel Horowitz, David Lavie, MD, Dina Ben Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MDM, MSc

Blood (2014) 124 (21): 4409.

https://doi.org/10.1182/blood.V124.21.4409.4409

Published: 2014

Journal Articles

Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia: Comparison Between Ethnic Populations in Israel

Ronit Elhasid, MD, Aya Abramov, MD, Nira Arad -Cohen, MD, Dina Attias, MD, Galia Avrahami, MD, Ami Ballin, MD, Myriam Ben Arush, Prof, Bella Bielorai, MD, Yoav Burstein, MD, Sara Elitzur, MD, Hertzel Gavriel, MD, Joseph Kapelushnik, Prof, Dalia Sthoeger, MD, Amos Toren, Prof, Isaac Yaniv, Prof, Michael Wientraub, MD, Ronit Nirel, MD, Shai Izraeli, Prof, Batia Stark, MD

Blood (2014) 124 (21): 2257.

https://doi.org/10.1182/blood.V124.21.2257.2257

Published: 2014

Journal Articles

Absolute Monocyte Count At Diagnosis Is a Poor Prognostic Factor and Impacts Survival in Diffuse Large B-Cell Lymphoma: A Collaborative Multi-Center Study Involving 1026 Patients.

Tamar Tadmor, MD, Bari Alessia, MD, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Irit Avivi, MD, Noam Benyamini, MD, Dina Attias, MD, Samantha Pozzi, MD, Massimo Federico, MD, Aaron Polliack, MD

Blood (2012) 120 (21): 2651.

https://doi.org/10.1182/blood.V120.21.2651.2651

Published: 2012

Journal Articles

Tailored Therapy In Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT, Can Lead to Modification and Safe Reduction In Therapy: Results of 134 Patients on the Israel National Hodgkin Study.

Eldad J. Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Marina Izak, MD, Abraham Korenberg, MD, Luiza Akria, MD, Dina Attias, MD, Kalman Filanovsky, MD, Liana Abdach, MD, Neta Goldschmidt, MD, Ron Epelbaum, MD, Jacob M. Rowe, MD, Dina Ben Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MSc, FRCPC

Blood (2010) 116 (21): 2809.

https://doi.org/10.1182/blood.V116.21.2809.2809

Published: 2010

Journal Articles

Enhanced Apoptosis and Reduced Angiogenesis in DLBCL.

Zahava Vadasz, MD, PhD, Tamar Tadmor, MD, Jacob Bejar, MD, Dina Attias, MD.

Blood (2005) 106 (11): 4681.

https://doi.org/10.1182/blood.V106.11.4681.4681

Published: 2005

NARROW

Semaphorin 3A Expression on Donor and Recipient Regulatory Cells: A Novel Pre-Transplant Biomarker Predicting the Development of Acute Graft-Versus-Host Disease

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia: Comparison Between Ethnic Populations in Israel

Absolute Monocyte Count At Diagnosis Is a Poor Prognostic Factor and Impacts Survival in Diffuse Large B-Cell Lymphoma: A Collaborative Multi-Center Study Involving 1026 Patients.

Tailored Therapy In Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT, Can Lead to Modification and Safe Reduction In Therapy: Results of 134 Patients on the Israel National Hodgkin Study.

Enhanced Apoptosis and Reduced Angiogenesis in DLBCL.

Email alerts

ASH Publications

American Society of Hematology

Semaphorin 3A Expression on Donor and Recipient Regulatory Cells: A Novel Pre-Transplant Biomarker Predicting the Development of Acute Graft-Versus-Host Disease

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia: Comparison Between Ethnic Populations in Israel

Absolute Monocyte Count At Diagnosis Is a Poor Prognostic Factor and Impacts Survival in Diffuse Large B-Cell Lymphoma: A Collaborative Multi-Center Study Involving 1026 Patients.

Tailored Therapy In Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT, Can Lead to Modification and Safe Reduction In Therapy: Results of 134 Patients on the Israel National Hodgkin Study.

Enhanced Apoptosis and Reduced Angiogenesis in DLBCL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only